F‐erythrocytes promote Plasmodium falciparum proliferation in sickle cell disease
American Journal of Hematology · 2023
DOI: 10.1002/ajh.27042 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Hematology, 2023. Verfasst von Natasha M Archer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Hematology/Oncology Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Plasmodium falciparum, Malaria, Falciparum. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Background
Sickle cell disease (SCD) remains prevalent because heterozygous carriers (HbAS) are partially resistant to Plasmodium falciparum malaria. Sickle hemoglobin (HbS) polymerization in low and intermediate oxygen (O 2 ) conditions is the main driver of HbAS‐driven resistance to P. falciparum malaria. However, epidemiological studies have reported mixed malaria morbidity and mortality outcomes in individuals with sickle cell disease (SCD). While maximum‐tolerated dose hydroxyurea has been shown to lower malaria incidence, fetal hemoglobin (HbF), an inhibitor of HbS polymerization that is variably packaged in F‐erythrocytes, might provide hemoglobin that is accessible to the parasite for feeding.
Methods
To explore that risk, we examined the effect of variable mean corpuscular fetal hemoglobin (MCHF) on P. falciparum proliferation, invasion, and development in HbSS RBCs.
Results
We found that greater MCHF in HbSS red blood cells (RBCs) is associated with increased P. falciparum proliferation in O 2 environments comparable with the microcirculation. Moreover, both parasite invasion and intracellular growth, the major components of proliferation, occur predominantly in F‐erythrocytes and are augmented with increasing MCHF.
Conclusions
HbF modifies P. falciparum infection in HbSS RBCs, further highlighting the complexity of the molecular interactions between these two diseases. Other inhibitors of HbS polymerization that do not increase HbF or F‐erythrocytes should be independently assessed for their effects on P. falciparum malaria proliferation in HbSS RBCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Pediatric Hematology/Oncology Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
- Center for Communicable Diseases Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
- The TransLab, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.
ORCID-Profile: Natasha M Archer, Manoj T Duraisingh
Förderung
- NIDDK NIH HHS
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Archer, N. M., Gnangnon, B., Mikdar, M., Ciuculescu, M. F., Petersen, N., Staffa, S. J., & Duraisingh, M. T. (2023). F‐erythrocytes promote Plasmodium falciparum proliferation in sickle cell disease. American Journal of Hematology. https://doi.org/10.1002/ajh.27042
Vancouver
Archer NM, Gnangnon B, Mikdar M, Ciuculescu MF, Petersen N, Staffa SJ, et al. F‐erythrocytes promote Plasmodium falciparum proliferation in sickle cell disease. American Journal of Hematology. 2023. doi:10.1002/ajh.27042
BibTeX
@article{Archer2023,
author = {Archer, Natasha M and Gnangnon, Bénédicte and Mikdar, Mahmoud and Ciuculescu, Marioara F and Petersen, Nicole and Staffa, Steven J and Duraisingh, Manoj T},
title = {F‐erythrocytes promote Plasmodium falciparum proliferation in sickle cell disease},
journal = {American Journal of Hematology},
year = {2023},
doi = {10.1002/ajh.27042}
}
EUVIMED